An updated review on systemic therapy for brain metastases in non-small cell lung cancer
Shreya Louis, John Paul Aboubechara, Keshav Saigal, Toni Cao, Seema Nagpal · 2025
Read An updated review on systemic therapy for brain metastases in non-small cell lung cancer by Shreya Louis, John Paul Aboubechara, Keshav Saigal, Toni Cao, Seema Nagpal (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12776225.txt.
Description
Shreya Louis, John Paul Aboubechara, Keshav Saigal, Toni Cao, and Seema Nagpal wrote this review, published in 2025. It updates the drug treatment landscape for brain metastases from non-small cell lung cancer. This spread strikes up to forty percent of patients and once left doctors with only surgery and radiation.
Newer targeted drugs and immunotherapies cross into the brain far better than old chemotherapy. They let some patients defer radiation and its side effects. The review walks through the main drug classes, their brain activity, and how they combine with local treatments. Two structural problems stand out. Trials still often exclude patients with brain spread. Those that include them measure brain responses inconsistently, so cross-drug comparisons stay murky. The authors call for trials designed with brain endpoints from the start.
Catalog record
| CREATOR | Shreya Louis, John Paul Aboubechara, Keshav Saigal, Toni Cao, Seema Nagpal |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |